8440 results
-
List item
Human medicine European public assessment report (EPAR): Dacogen (updated)
decitabine, Leukemia, Myeloid
Date of authorisation: 20/09/2012, Revision: 11, Authorised -
List item
Human medicine European public assessment report (EPAR): Dificlir (updated)
fidaxomicin, Clostridium Infections
Date of authorisation: 05/12/2011, Additional monitoring, Revision: 11, Authorised -
List item
Human medicine European public assessment report (EPAR): Abseamed (updated)
epoetin alfa, Anemia Kidney Failure, Chronic Cancer
Date of authorisation: 27/08/2007, Biosimilar, Revision: 20, Authorised -
List item
Human medicine European public assessment report (EPAR): Aubagio (updated)
teriflunomide, Multiple Sclerosis
Date of authorisation: 26/08/2013, Revision: 10, Authorised -
List item
Human medicine European public assessment report (EPAR): Respreeza (updated)
alpha1-proteinase inhibitor (human), Genetic Diseases, Inborn Lung Diseases
Date of authorisation: 20/08/2015, Additional monitoring, Revision: 5, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Bovilis Blue-8 (updated)
bluetongue virus vaccine, serotype 8 (inactivated), Cattle Sheep
Date of authorisation: 21/11/2017, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): Verzenios (updated)
abemaciclib, Breast Neoplasms
Date of authorisation: 26/09/2018, Additional monitoring, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): Nexium Control (updated)
esomeprazole, Gastroesophageal Reflux
Date of authorisation: 26/08/2013, Revision: 12, Authorised -
List item
Human medicine European public assessment report (EPAR): Peyona (previously Nymusa) (updated)
caffeine, Apnea
Date of authorisation: 02/07/2009, Revision: 9, Authorised -
List item
Human medicine European public assessment report (EPAR): Maviret (updated)
glecaprevir / pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017, Additional monitoring, Revision: 4, Authorised -
List item
Human medicine European public assessment report (EPAR): Tractocile (updated)
atosiban, Premature Birth
Date of authorisation: 20/01/2000, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Zypadhera (updated)
olanzapine, Schizophrenia
Date of authorisation: 19/11/2008, Revision: 18, Authorised -
List item
Human medicine European public assessment report (EPAR): Tegsedi (updated)
inotersen, Amyloidosis
Date of authorisation: 05/07/2018, Additional monitoring, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Orfadin (updated)
nitisinone, Tyrosinemias
Date of authorisation: 20/02/2005, Revision: 15, Authorised -
List item
Human medicine European public assessment report (EPAR): Prevymis (updated)
letermovir, Cytomegalovirus Infections
Date of authorisation: 08/01/2018, Additional monitoring, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): NutropinAq (updated)
somatropin, Turner Syndrome Dwarfism, Pituitary
Date of authorisation: 15/02/2001, Revision: 16, Authorised -
List item
Human medicine European public assessment report (EPAR): Inovelon (updated)
rufinamide, Epilepsy
Date of authorisation: 16/01/2007, Revision: 18, Authorised -
List item
Human medicine European public assessment report (EPAR): Opsumit (updated)
macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Rotarix (updated)
rotavirus vaccine, live, attenuated, Immunization Rotavirus Infections
Date of authorisation: 21/02/2006, Revision: 29, Authorised -
List item
Human medicine European public assessment report (EPAR): Rasilez (updated)
aliskiren, Hypertension
Date of authorisation: 22/08/2007, Revision: 24, Authorised -
List item
Human medicine European public assessment report (EPAR): Rasilez HCT (updated)
aliskiren / hydrochlorothiazide, Hypertension
Date of authorisation: 16/01/2009, Revision: 16, Authorised -
List item
Human medicine European public assessment report (EPAR): Targretin (updated)
bexarotene, Lymphoma, T-Cell, Cutaneous
Date of authorisation: 29/03/2001, Revision: 19, Authorised -
List item
Human medicine European public assessment report (EPAR): Epoetin Alfa Hexal (updated)
epoetin alfa, Anemia Kidney Failure, Chronic Cancer
Date of authorisation: 27/08/2007, Biosimilar, Revision: 20, Authorised -
List item
Human medicine European public assessment report (EPAR): Cresemba (updated)
isavuconazole, Aspergillosis
Date of authorisation: 15/10/2015, Additional monitoring, Revision: 4, Authorised -
List item
Human medicine European public assessment report (EPAR): Voncento (updated)
human coagulation factor VIII / human von willebrand factor, Hemophilia A von Willebrand Diseases
Date of authorisation: 12/08/2013, Revision: 11, Authorised